-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Dow Jones·08/07/2026 20:01:00

Please log in to view news